Treating hypertension in older adults: safety considerations. - Wikidata - awgldk - TriplyDB

Treating hypertension in older adults: safety considerations.

Treating hypertension in older adults: safety considerations.

http://www.wikidata.org/entity/Q33157131

about

Predicting risk of adverse drug reactions in older adults Combining machine learning, crowdsourcing and expert knowledge to detect chemical-induced diseases in text Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management.Adverse drug events are a major cause of acute medical admission.Role of systems pharmacology in understanding drug adverse events.Reducing fall risk while managing hypotension, pain, and poor sleep in an 83-year-old woman.Identifying and managing drug-related causes of common geriatric symptoms.Genetic influence on exercise-induced changes in physical function among mobility-limited older adults.Elderly users of fall-risk-increasing drug perceptions of fall risk and the relation to their drug use - a qualitative study.Depression and medication adherence among older Korean patients with hypertension: Mediating role of self-efficacy.Reducing pill burden and helping with medication awareness to improve adherence Reducing fall risk while managing pain and insomnia: Addressing polypharmacy in an 81-year-old woman

P2860

Q26770379-F288EBD3-B990-453B-BA7E-107C4797433C Q28830244-F73E1AA1-7F83-45F5-8566-44694D27B818 Q33160283-3CEE3324-BCBC-4078-B0FA-EB5C20DCB08D Q33164169-E1C916A9-2A76-42A8-B2B5-2EC2F3DBBC72 Q34134791-5CE5829E-5430-4674-9A5E-1FF8B53EAC1D Q37387535-F947C1CC-EE3C-4899-B2A6-7E3C2AB45037 Q37580557-04C0806F-2C6E-4079-9BAB-10179FEE3900 Q37629357-29E5ED41-1DB6-4704-B528-A3BF8C61E844 Q38631887-91947D9C-CCFC-470B-AFE6-8D4F6F364804 Q38757872-0704BAA2-795A-4CAC-97B7-5C2200E2EB36 Q41895173-F3BF2565-A828-438C-AA1C-5273C119728F Q42094275-FEFC06FD-A7A2-4D7A-8D5D-B7525A525B2A

P2860

Treating hypertension in older adults: safety considerations.

http://www.wikidata.org/entity/Q33157131

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Treating hypertension in older adults: safety considerations.

@ast

Treating hypertension in older adults: safety considerations.

@en

type

label

Treating hypertension in older adults: safety considerations.

@ast

Treating hypertension in older adults: safety considerations.

@en

prefLabel

Treating hypertension in older adults: safety considerations.

@ast

Treating hypertension in older adults: safety considerations.

@en

P1433

Q33157131-D725AF78-FC2F-4A06-A625-6F49A3A89793

P1476

Q33157131-FCE8BF8B-7D17-4098-AB07-75FB1C85E82A

P2093

Q33157131-6D1089A9-A951-4392-8E24-34FE06E860DF

P2860

Q33157131-2DFC3DB5-02DF-4E79-8016-1A1353F32AF2

Q33157131-5B29E785-B77E-4ED5-8725-6837E4800262

Q33157131-73BD7E88-8A5F-4798-AE73-4D22323F8052

Q33157131-9019C386-5C84-4DAC-BDB6-F3BC8299C197

Q33157131-9E4E9259-4903-423A-BD02-1FE76DF51800

Q33157131-A15A20B1-509A-41DB-8300-82B8B69E3FD9

Q33157131-CDEB43C4-6255-4152-BC99-F5ADDEFFBF40

Q33157131-CF5BA303-00D6-438A-89CD-A3F0B96B1F23

Q33157131-D1034023-364C-447A-A01E-FDF1BD029F7F

Q33157131-E50D009E-8F8C-44D0-9563-2120E3B00D32

P2888

Q33157131-415C70C6-938F-4940-831C-B1E44A790629

P304

Q33157131-22DC077A-DD0C-4B25-B8D4-84C97CF077F0

P31

Q33157131-82E34014-99D1-42EF-A848-1C0ED7E91A66

P356

Q33157131-63042AB3-1F48-4A96-8E1F-7007A346F7C8

P433

Q33157131-B79F6D79-EE17-46F8-B1AB-A1C72B58427B

P478

Q33157131-69EE9052-8CF5-4290-AADF-14673784E471

P577

Q33157131-86EF8A89-72E0-4255-B64A-17CAEEDB2D8F

P6179

Q33157131-D7C0CEC4-E035-4908-A033-7DBB0662678C

P698

Q33157131-676059D5-F9D5-4ADA-B78C-28BD35234C4F

P356

00002018-200932020-00004

P1433

P1476

Treating hypertension in older adults: safety considerations.

@en

P2093

Wilbert S Aronow

http://www.w3.org/2001/XMLSchema#string

P2860

Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Postprandial hypotension in 499 elderly persons in a long-term health care facility.

Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents.

Effect of age and high blood pressure on baroreflex sensitivity in man.

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Embracing complexity: A consideration of hypertension in the very old.

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.

P2888

00002018-200932020-00004

P304

111-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/00002018-200932020-00004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049252027

http://www.w3.org/2001/XMLSchema#string

P698

19236118

http://www.w3.org/2001/XMLSchema#string